fashion -WSS

fashion

author：knowledge 2025-10-02 22:58:49 - browse：2

Sammy Kimball for STAT

What can Homer teach us about biotech? Has Big Science gotten too big? And what’s the future of treating Alzheimer’s disease?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Neil Kumar, CEO of BridgeBio, joins us to talk about how his small company came to develop what could be a big drug — and why classical Greek literature remains relevant. We also discuss the latest news in the life sciences, including the abrupt resignation of the celebrity scientist who led Stanford University and the implications of tornado damage at a Pfizer plant.

For more on what we cover, here’s the news on BridgeBio; here’s more on the Stanford president; here’s the latest on the Pfizer plant; here’s the story on Eli Lilly’s Alzheimer’s data; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： ALS groups 'won't be played again' by the FDA, drug sponsors

leisure time

WSS

In search for therapies for solid tumors, companies turn to claudin

Congress gives doctors Medicare pay bump

Congress must reauthorize a committee to support older Americans

Why getting cancer drugs just got harder for rural patients

Covid isolation guidance eased by the CDC

Morphosys mixed study results for blood cancer drug

hotspot

fashion

hotspot

Medicare details structure of new drug price negotiation program

Ransomware attacks on hospitals: Study outlines patient impact

In Memoriam: Notable people who died in 2023

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

New air purifier tech could be key to improving indoor air quality

Why getting cancer drugs just got harder for rural patients

Hepatitis C has a cure — but many Americans still lack access to it

How to fix the rural physician shortage in the U.S.

Peter Hotez and the public health issue of online harassment

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

explore

Ransomware attacks on hospitals: Study outlines patient impact

Flu vaccine offering decent levels of protection this winter, new data show

International team creates first chimeric human

In key trial, Verve's treatment lowers cholesterol levels in patients

David Sabatini, ex

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

leisure time

hotspot

entertainment

hotspot